🔎 Trials Near Me

Gara Jalqabaatti › Sklerosis Baay’ee › Maryland › Baltimore

Qorannoo klinikaalii Sklerosis Baay’ee Baltimore, MD keessatti

Qorannoo 7 Sklerosis Baay’ee f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • TG Therapeutics Investigational Trial Site, Baltimore
  • TG Therapeutics Investigational Trial Site, Glen Burnie · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Namoota walitti qabaa jiraSadarkaa 2
  • Sheppard Pratt, Towson · Miili 8 fagaatti
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Namoota walitti qabaa jiraSadarkaa 3
  • Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07325292

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Namoota walitti qabaa jiraSadarkaa 2
  • Johns Hopkins University, Baltimore
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT07497399

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Namoota walitti qabaa jiraSadarkaa 2
  • Johns Hopkins University, Baltimore
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT06170970

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

Namoota walitti qabaa jiraSadarkaa 4
  • Johns Hopkins University, Baltimore
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07389590

Qorannoo Sklerosis Baay’ee magaalota biroo keessatti

Qorannoo biroo Baltimore keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.